NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Thermo Fisher Scientific Wins LIMS Contract from University of Miami Miller School of Medicine - Thermo Fisher Scientific Inc., the world leader in serving science announced today that the University of Miami Miller School of Medicine has awarded the company a contract for its Nautilus LIMS (Laboratory Information Management System)
Thermo Fisher Scientific Wins LIMS Contract from University of Miami Miller School of Medicine

 

NewswireTODAY - /newswire/ - PHILADELPHIA, PA, United States, 2008/10/13 - Thermo Fisher Scientific Inc., the world leader in serving science announced today that the University of Miami Miller School of Medicine has awarded the company a contract for its Nautilus LIMS (Laboratory Information Management System).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

For use in the medical school's spinal cord injury research. During the project, scientists will integrate Thermo Scientific Nautilus LIMS with other Thermo Scientific instrumentation and robotics to automate the high-content screening in the laboratories of The Miami Project to Cure Paralysis at the Miller School.

The Miami Project to Cure Paralysis is the world's largest spinal cord injury research center, looking for new treatments by understanding injury mechanisms and researching treatments to prevent cell death after spinal cord injury. Vance Lemmon, Ph.D., professor of neurological surgery, co-directs the Laboratory for Axon Growth and Guidance at The Miami Project to Cure Paralysis, which investigates genes involved in axon growth and guidance during nervous system development and regeneration subsequent to spinal cord injury.

"Our work is accomplished using a technology called High Content Screening, an area in which Thermo Fisher excels," said Dr. Lemmon. "High Content Screening generates very large quantities of data, which the laboratory previously managed via manual methods such as spreadsheets, notebooks, and databases."

Dr. Lemmon's experiments take advantage of extensive compound and gene collections stored in 96-well plates. The Miami Project team selected Nautilus LIMS because they believe it could help them successfully keep abreast of the large volumes of data and keep track of the reagents in hundreds of 96 well plates. During the selection process they also underscored the versatility of Nautilus and its proven ability to manage plate data and to adapt to the workflow needs of the academic laboratory.

Because of the nature of the translational clinical research underway at The Miami Project to Cure Paralysis, the laboratory uses complex and rapidly changing workflows. Twenty academic research scientists work collaboratively on many different experiments, but the manual nature of their current recordkeeping makes it impossible to track and access the growing number of experimental results. Dr. Lemmon required a LIMS that could easily and rapidly capture all the data from the experiments, as well as one that could quickly identify raw materials used in the experiments since reagent quality can have a significant impact on the results. The laboratory looked at 10 LIMS suppliers and found that Thermo Scientific Nautilus offered the best plate handling tools (the laboratory uses many multi-well plates) and its workflow functionality allowed the laboratory to track its experiments and capture their complicated results in a way no other LIMS demonstrated.

"My laboratory has seen an explosion in the number of cells we analyze - to levels around 250,000 per week with hundreds of molecular treatments - and we needed to be able to access that data and analyze it to give us knowledge that was not otherwise available without the LIMS," said Dr. Lemmon. "Our academic processes are now so complex and Nautilus will give us the information we were struggling to extract."

Nautilus LIMS will sit at the heart of the laboratory's operations, and it will be integrated with Thermo Scientific Arrayscan and Cellomics KineticScan instruments and robotics. The scientists will use Nautilus LIMS to automate the high-content screens and assays including priotorized planning of experiments in the laboratory and, equally important, for raw materials inventory management to identify faulty reagent batches which are impossible to track back through paper notebooks.

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With annual revenues of $10 billion, we have more than 30,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike.

Miller School of Medicine Boilerplate
The University of Miami Leonard M. Miller School of Medicine, founded in 1952, was the first medical school in the state of Florida. The Miller School of Medicine is located on the 100-acre University of Miami/Jackson Memorial Medical Center complex in Miami. The medical center includes three University-owned hospitals that make up the University of Miami Health System (UHealth): University of Miami Hospital, Sylvester Comprehensive Cancer Center and Bascom Palmer Eye Institute. Our three primary affiliated hospitals on the campus include Jackson Memorial Hospital, Holtz Children's Hospital and the Miami VA Medical Center. Miller School faculty members conduct more than 1,700 research projects in basic science and clinical care in facilities totaling more than 500,000 square feet of research space. Along with the M.D. degree, the school offers two specialized B.S./M.D. programs, a combined M.D./Ph.D. program, graduate degrees in nine areas, postdoctoral programs and continuing medical education courses.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Thermo Fisher Scientific Wins LIMS Contract from University of Miami Miller School of Medicine

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Kath Darlington 
+44(0)14 7753 9539 marketing.informatics[.]thermofisher.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Withings Enhances Cardiovascular Solutions At CES 2025 with BPM Vision and Cardio Check-Up
XenMD Introduces Healthcare Revenue Cycle Management with Expert Accounts Receivable (AR) Recovery Services
Bruker Introduces Dimension Nexus™ Atomic Force Microscope
Predictive Heart Monitoring Startup GPX Secures New Investment from NEC X - Joins Elev X! Boost Venture Studio Program
Bruker Announces EpicIF™, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform
Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics
Bruker Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging
ams OSRAM Strengthens its Leadership in Medical Innovation with the Opening of A New Design Center in the Heart of Valencia
TDK and Tokyo Medical and Dental University Measure Cardiac Activity Using High Sensitivity MR Sensor Array Outside A Magnetically Shielded Room
Environmental Compliance and Pharmaceutical Quality Standards Pave the Way for Transformational Growth in Chromatography
SCHOTT Group Wins Gold Stevie Awards for Technology Excellence with SCHOTT TOPPAC® Nest 160 and Lightweight Microelectronic Packages
SCHOTT Pharma Introduces Nest Design with More Cavities for Prefillable Polymer Syringes
SCHOTT Pharma Launches Large Format Ready-to-Use Cartridges for On-body Devices
Nexans Invests in its Draveil Site to Double Production Capacity of Medical Cables
SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  RightITnow, Inc.





 
  ©2005-2025 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)